Prevalence and risk factors of white-coat hypertension and masked hypertension in Shunde District,Southern China:Observational Study (Preprint)

2021 ◽  
Author(s):  
Yuli Huang ◽  
Haoxiao Zheng ◽  
Xiaoyan Liang ◽  
Chunyi Huang ◽  
Lichang Sun ◽  
...  
Keyword(s):  
Risk Factors ◽  
Blood Pressure ◽  
Family History ◽  
Blood Pressure Monitoring ◽  
Home Blood Pressure ◽  
White Coat ◽  
White Coat Hypertension ◽  
Masked Hypertension ◽  
Pressure Monitoring ◽  
History Of

BACKGROUND White-coat hypertension (WCH) and masked hypertension (MH) can increase the risk of target organ damage. Home blood pressure monitoring is an important method for detecting WCH and MH. However, the prevalence and risk factors of WCH and MH in China has been rarely reported. OBJECTIVE To explore the prevalence and risk factors associated with white coat hypertension (WCH) and masked hypertension (MH) in Shunde District, Southern China. METHODS This study recruited subjects from the Physical Examination Center in Shunde Hospital, Southern Medical University. Office blood pressure and home blood pressure values were collected. The prevalence of WCH and MH was calculated by combining the office blood pressure and home blood pressure values. Multivariate logistic regression was used to explore the related risk factors for WCH and MH. RESULTS Four-hundred and sixty-one participants (61% male), with an average age of 49 years, were included. The incidence of WCH and MH was 5.1% and 15.2%, respectively. Multivariate logistic regression analysis showed that smoking (OR=4.71, 95%CI=1.05-21.15) and family history of coronary heart disease (OR=4.51, 95%CI=1.08-18.93) were associated with higher odds of WCH. The associated factors for higher odds of MH were smoking (OR=2.83, 95%CI=1.11-7.23), family history of hypertension (OR=2.17, 95%CI=1.11-4.26) and family history of coronary heart disease (OR=2.82, 95%CI=1.07-7.45). CONCLUSIONS WCH and MH are highly prevalent in the health check-up population in Southern China. Out-of-office blood pressure monitoring, especially home blood pressure monitoring with a telemedicine device should be recommended to identity abnormal BP phenotype. CLINICALTRIAL It has been registered in the Chinese Clinical Trial Registry(ChiCTR1800018515)

scholarly journals Patient Barriers and Facilitators to Ambulatory and Home Blood Pressure Monitoring: A Qualitative Study

2018 ◽  
Vol 31 (8) ◽  
pp. 919-927 ◽  
Author(s):  
Eileen J Carter ◽  
Nathalie Moise ◽  
Carmela Alcántara ◽  
Alexandra M Sullivan ◽  
Ian M Kronish
Keyword(s):  
Blood Pressure ◽  
New York ◽  
Blood Pressure Monitoring ◽  
Home Blood Pressure ◽  
Barriers And Facilitators ◽  
White Coat ◽  
White Coat Hypertension ◽  
Home Blood Pressure Monitoring ◽  
Pressure Monitoring ◽  
Monitoring Method

Abstract BACKGROUND Guidelines recommend that patients with newly elevated office blood pressure undergo ambulatory blood pressure monitoring (ABPM) or home blood pressure monitoring (HBPM) to rule-out white coat hypertension before being diagnosed with hypertension. We explored patients’ perspectives of the barriers and facilitators to undergoing ABPM or HBPM. METHODS Focus groups were conducted with twenty English- and Spanish-speaking individuals from underserved communities in New York City. Two researchers analyzed transcripts using a conventional content analysis to identify barriers and facilitators to participation in ABPM and HBPM. RESULTS Participants described favorable attitudes toward testing including readily understanding white coat hypertension, agreeing with the rationale for out-of-office testing, and believing that testing would benefit patients. Regarding ABPM, participants expressed concerns over the representativeness of the day the test was performed and the intrusiveness of the frequent readings. Regarding HBPM, participants expressed concerns over the validity of the monitoring method and the reliability of home blood pressure devices. For both tests, participants noted that out-of-pocket costs may deter patient participation and felt that patients would require detailed information about the test itself before deciding to participate. Participants overwhelmingly believed that out-of-office testing benefits outweighed testing barriers, were confident that they could successfully complete either testing if recommended by their provider, and described the rationale for their testing preference. CONCLUSIONS Participants identified dominant barriers and facilitators to ABPM and HBPM testing, articulated testing preferences, and believed that they could successfully complete out-of-office testing if recommended by their provider.

Abstract 16606: Home Blood Pressure Monitoring Postpartum Detects Masked Hypertension in Women With a History of Preeclampsia

Circulation ◽  
2020 ◽  
Vol 142 (Suppl_3) ◽  
Author(s):  
Virginia R Nuckols ◽  
Amy K Stroud ◽  
Debra Brandt ◽  
Mark K Santillan ◽  
Donna A Santillan ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Disease Risk ◽  
Blood Pressure Monitoring ◽  
Cardiovascular Disease Risk ◽  
Home Blood Pressure ◽  
Chronic Hypertension ◽  
Masked Hypertension ◽  
Home Blood Pressure Monitoring ◽  
Pressure Monitoring ◽  
History Of

Introduction: One-third of women with a history of preeclampsia (hxPE), a hypertensive pregnancy disorder, develop chronic hypertension (HTN) within five years postpartum. Twenty-four hour ambulatory blood pressure monitoring (ABPM) shows that 12% of women with hxPE have ‘masked’ HTN. Masked HTN is undetected in routine clinical assessment but is associated with elevated cardiovascular disease risk. ABPM (gold-standard) or home blood pressure monitoring (HBPM) is needed to identify masked HTN. HBPM is a well-tolerated, inexpensive alternative to ABPM. However, the ability of HBPM to detect masked postpartum HTN using new AHA/ACC HTN guidelines is unknown. The purpose of this study was to compare ABPM and HBPM in the identification of masked and sustained HTN among young women with hxPE and healthy pregnancy (HP) controls 1-3 years postpartum. Methods: Women with hxPE (N=22; age 33 ± 5 yrs) and HP controls (N=26; age 34 ± 4 yrs) were assessed 18 ± 6 months postpartum. Seated office blood pressure (BP) was collected with an automated brachial cuff and averaged over three trials. ABPM (Mobil-o-graph) was conducted with a portable, automated brachial cuff and averaged over 38 ± 2 awake and asleep BP recordings. Participants completed HBPM (Microlife) morning and evening for seven consecutive days. BP thresholds for HTN were determined according to 2017 AHA/ACC clinical guidelines. Results: HTN was more prevalent among women with hxPE compared with HP assessed by office BP (59 vs. 15 %, P=0.002) and ABPM (68 vs. 31 %, P=0.01) but not HBPM (41 vs 19 %, P=0.10). The prevalence of masked HTN did not differ between women with hxPE and HP (14 vs. 19%, P=0.71) assessed by ABPM. In the entire cohort, HBPM detected 50% of masked HTN cases identified by ABPM. HBPM agreed with ABPM on HTN status (κ = 0.49, P=0.002). HBPM and ABPM detected uncontrolled HTN in three of four women with hxPE prescribed anti-hypertensive medication. Conclusion: HxPE is associated with a higher prevalence of HTN 1-3 yrs postpartum compared with controls, but the prevalence of masked HTN did not differ. ABPM and HBPM showed concordant classification of HTN using current BP guidelines. These findings indicate that HBPM may be a valuable pre-screening tool for early identification and management of HTN postpartum.

scholarly journals Impact of 2017 ACC/AHA hypertension guidelines on the prevalence of white‐coat and masked hypertension: A home blood pressure monitoring study

2018 ◽  
Vol 20 (12) ◽  
pp. 1745-1747 ◽  
Author(s):  
Audes D. M. Feitosa ◽  
Marco A. Mota‐Gomes ◽  
Roberto D. Miranda ◽  
Weimar S. Barroso ◽  
Eduardo C. D. Barbosa ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Blood Pressure Monitoring ◽  
Home Blood Pressure ◽  
White Coat ◽  
Masked Hypertension ◽  
Home Blood Pressure Monitoring ◽  
Pressure Monitoring ◽  
Hypertension Guidelines ◽  
Monitoring Study
Sign in / Sign up

Export Citation Format

Share Document